|
1
|
Fernández-del Castillo C and Adsay NV:
Intraductal papillary mucinous neoplasms of the pancreas.
Gastroenterology. 139(708–713): e1–2. 2010.
|
|
2
|
Adsay NV, Conlon KC, Zee SY, Brennan MF
and Klimstra DS: Intraductal papillary-mucinous neoplasms of the
pancreas: An analysis of in situ and invasive carcinomas in 28
patients. Cancer. 94:62–77. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fernández-del Castillo C, Targarona J,
Thayer SP, Rattner DW, Brugge WR and Warshaw AL: Incidental
pancreatic cysts: Clinicopathologic characteristics and comparison
with symptomatic patients. Arch Surg. 138:427–434. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andrejevic-Blant S, Kosmahl M, Sipos B and
Klöppel G: Pancreatic intraductal papillary-mucinous neoplasms: A
new and evolving entity. Virchows Arch. 451:863–869. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kosmahl M, Pauser U, Peters K, Sipos B,
Lüttges J, Kremer B and Klöppel G: Cystic neoplasms of the pancreas
and tumor-like lesions with cystic features: A review of 418 cases
and a classification proposal. Virchows Arch. 445:168–178. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balzano G, Zerbi A and Di Carlo V:
Intraductal papillary mucinous tumors of the pancreas: Incidence,
clinical findings and natural history. JOP. 6 1 Suppl:S108–S111.
2005.
|
|
7
|
Hruban RH and Klimsra DS: Intraductal
neoplasms. Hruban RH, Pitman MB and Klimsstra DS: AFIP Atlas of
Tumor Pathology, Series 4: Tumors of the Pancreas. 2007.
|
|
8
|
Nara S, Shimada K, Kosuge T, Kanai Y and
Hiraoka N: Minimally invasive intraductal papillary-mucinous
carcinoma of the pancreas: Clinicopathologic study of 104
intraductal papillary-mucinous neoplasms. Am J Surg Pathol.
32:243–255. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krasinskas AM, Moser AJ, Saka B, Adsay NV
and Chiosea SI: KRAS mutant allele-specific imbalance is associated
with worse prognosis in pancreatic cancer and progression to
undifferentiated carcinoma of the pancreas. Mod Pathol.
26:1346–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sessa F, Solcia E, Capella C, Bonato M,
Scarpa A, Zamboni G, Pellegata NS, Ranzani GN, Rickaert F and
Klöppel G: Intraductal papillary-mucinous tumours represent a
distinct group of pancreatic neoplasms: An investigation of tumour
cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in
26 patients. Virchows Arch. 425:357–367. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tada M, Omata M and Ohto M: Ras gene
mutations in intraductal papillary neoplasms of the pancreas.
Analysis in five cases. Cancer. 67:634–637. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Satoh K, Shimosegawa T, Moriizumi S,
Koizumi M and Toyota T: K-ras mutation and p53 protein accumulation
in intraductal mucin-hypersecreting neoplasms of the pancreas.
Pancreas. 12:362–368. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Satoh K, Sawai T, Shimosegawa T, Koizumi
M, Yamazaki T, Mochizuki F and Toyota T: The point mutation of
c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and
in intraductal mucin-hypersecreting neoplasm of the pancreas. Int J
Pancreatol. 14:135–143. 1993.PubMed/NCBI
|
|
14
|
Uemura K, Hiyama E, Murakami Y, Kanehiro
T, Ohge H, Sueda T and Yokoyama T: Comparative analysis of K-ras
point mutation, telomerase activity, and p53 overexpression in
pancreatic tumours. Oncol Rep. 10:277–283. 2003.PubMed/NCBI
|
|
15
|
Oliveira-Cunha M, Hadfield KD, Siriwardena
AK and Newman W: EGFR and KRAS mutational analysis and their
correlation to survival in pancreatic and periampullary cancer.
Pancreas. 41:428–434. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim ST, Lim DH, Jang KT, Lim T, Lee J,
Choi YL, Jang HL, Yi JH, Baek KK, Park SH, et al: Impact of KRAS
mutations on clinical outcomes in pancreatic cancer patients
treated with first-line gemcitabine-based chemotherapy. Mol Cancer
Ther. 10:1993–1999. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schultz NA, Roslind A, Christensen IJ,
Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann
M and Johansen JS: Frequencies and prognostic role of KRAS and BRAF
mutations in patients with localized pancreatic and ampullary
adenocarcinomas. Pancreas. 41:759–766. 2012.PubMed/NCBI
|
|
18
|
Bournet B, Muscari F, Guimbaud R,
Cordelier P and Buscail L: KRAS mutations and their correlation
with survival of patients with advanced pancreatic cancer.
Pancreas. 42:543–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Z'Graggen K, Rivera JA, Compton CC, Pins
M, Werner J, Fernández-del Castillo C, Rattner DW, Lewandrowski KB,
Rustgi AK and Warshaw AL: Prevalence of activating K-ras mutations
in the evolutionary stages of neoplasia in intraductal papillary
mucinous tumors of the pancreas. Ann Surg. 226:491–500. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schönleben F, Qiu W, Ciau NT, Ho DJ, Li X,
Allendorf JD, Remotti HE and Su GH: PIK3CA mutations in intraductal
papillary mucinous neoplasm/carcinoma of the pancreas. Clin Cancer
Res. 12:3851–3855. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshizawa K, Nagai H, Sakurai S, Hironaka
M, Morinaga S, Saitoh K and Fukayama M: Clonality and K-ras
mutation analyses of epithelia in intraductal papillary mucinous
tumor and mucinous cystic tumor of the pancreas. Virchows Arch.
441:437–443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Matthaei H, Maitra A, Dal Molin M,
Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, et
al: Recurrent GNAS mutations define an unexpected pathway for
pancreatic cyst development. Sci Transl Med. 3:92ra662011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Furukawa T, Kuboki Y, Tanji E, Yoshida S,
Hatori T, Yamamoto M, Shibata N, Shimizu K, Kamatani N and
Shiratori K: Whole-exome sequencing uncovers frequent GNAS
mutations in intraductal papillary mucinous neoplasms of the
pancreas. Sci Rep. 1:1612011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swerdlow SH, Campo E and Harris NL: WHO
classification of tumors of the digestive system. 4th edition.
IARC; pp. 304–313. 2010
|
|
25
|
Bando H, Tsuchihara K, Yoshino T, Kojima
M, Ogasawara N, Fukushima H, Ochiai A, Ohtsu A and Esumi H: Biased
discordance of KRAS mutation detection in archived colorectal
cancer specimens between the ARMS-Scorpion method and direct
sequencing. Jpn J Clin Oncol. 41:239–244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Franklin WA, Haney J, Sugita M, Bemis L,
Jimeno A and Messersmith WA: KRAS mutation: Comparison of testing
methods and tissue sampling techniques in colon cancer. J Mol
Diagn. 12:43–50. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Adsay NV, Merati K, Basturk O,
Iacobuzio-Donahue C, Levi E, Cheng JD, Sarkar FH, Hruban RH and
Klimstra DS: Pathologically and biologically distinct types of
epithelium in intraductal papillary mucinous neoplasms: Delineation
of an ‘intestinal’ pathway of carcinogenesis in the pancreas. Am J
Surg Pathol. 28:839–848. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hruban RH, Takaori K, Klimstra DS, Adsay
NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C,
Fukushima N, Furukawa T, et al: An illustrated consensus on the
classification of pancreatic intraepithelial neoplasia and
intraductal papillary mucinous neoplasms. Am J Surg Pathol.
28:977–987. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lüttges J, Zamboni G, Longnecker D and
Klöppel G: The immunohistochemical mucin expression pattern
distinguishes different types of intraductal papillary mucinous
neoplasms of the pancreas and determines their relationship to
mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg
Pathol. 25:942–948. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Furukawa T, Klöppel G, Adsay Volkan N,
Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y,
Klimstra DS, Longnecker DS, et al: Classification of types of
intraductal papillary-mucinous neoplasm of the pancreas: A
consensus study. Virchows Arch. 447:794–799. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakamura A, Horinouchi M, Goto M, Nagata
K, Sakoda K, Takao S, Imai K, Kim YS, Sato E and Yonezawa S: New
classification of pancreatic intraductal papillary-mucinous tumour
by mucin expression: Its relationship with potential for
malignancy. J Pathol. 197:201–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tanaka M, Chari S, Adsay V, Fernandez-del
Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K and Matsuno
S: International Association of Pancreatology: International
consensus guidelines for management of intraductal papillary
mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Pancreatology. 6:17–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mino-Kenudson M, Fernández-del Castillo C,
Baba Y, Valsangkar NP, Liss AS, Hsu M, Correa-Gallego C, Ingkakul
T, Johnston Perez R, Turner BG, et al: Prognosis of invasive
intraductal papillary mucinous neoplasm depends on histological and
precursor epithelial subtypes. Gut. 60:1712–1720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Furukawa T, Hatori T, Fujita I, Yamamoto
M, Kobayashi M, Ohike N, Morohoshi T, Egawa S, Unno M, Takao S, et
al: Prognostic relevance of morphological types of intraductal
papillary mucinous neoplasms of the pancreas. Gut. 60:509–516.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kang MJ, Lee KB, Jang JY, Han IW and Kim
SW: Evaluation of clinical meaning of histological subtypes of
intraductal papillary mucinous neoplasm of the pancreas. Pancreas.
42:959–966. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Poultsides GA, Reddy S, Cameron JL, Hruban
RH, Pawlik TM, Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA,
Schulick RD and Wolfgang CL: Histopathologic basis for the
favorable survival after resection of intraductal papillary
mucinous neoplasm-associated invasive adenocarcinoma of the
pancreas. Ann Surg. 251:470–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adsay NV, Pierson C, Sarkar F, Abrams J,
Weaver D, Conlon KC, Brennan MF and Klimstra DS: Colloid (mucinous
noncystic) carcinoma of the pancreas. Am J Surg Pathol. 25:26–42.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sadakari Y, Ohuchida K, Nakata K, Ohtsuka
T, Aishima S, Takahata S, Nakamura M, Mizumoto K and Tanaka M:
Invasive carcinoma derived from the nonintestinal type intraductal
papillary mucinous neoplasm of the pancreas has a poorer prognosis
than that derived from the intestinal type. Surgery. 147:812–817.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takasu N, Kimura W, Moriya T, Hirai I,
Takeshita A, Kamio Y and Nomura T: Intraductal papillary-mucinous
neoplasms of the gastric and intestinal types may have less
malignant potential than the pancreatobiliary type. Pancreas.
39:604–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Moskaluk CA, Hruban RH and Kern SE: p16
and K-ras gene mutations in the intraductal precursors of human
pancreatic adenocarcinoma. Cancer Res. 57:2140–2143.
1997.PubMed/NCBI
|
|
41
|
Rozenblum E, Schutte M, Goggins M, Hahn
SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ and
Kern SE: Tumor-suppressive pathways in pancreatic carcinoma. Cancer
Res. 57:1731–1734. 1997.PubMed/NCBI
|
|
42
|
Schonleben F, Qiu W, Remotti HE,
Hohenberger W and Su GH: PIK3CA, KRAS, and BRAF mutations in
intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the
pancreas. Langenbecks Arch Surg. 393:289–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chadwick B, Willmore-Payne C, Tripp S,
Layfield LJ, Hirschowitz S and Holden J: Histologic,
immunohistochemical, and molecular classification of 52 IPMNs of
the pancreas. Appl Immunohistochem Mol Morphol. 17:31–39. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Izeradjene K, Combs C, Best M, Gopinathan
A, Wagner A, Grady WM, Deng CX, Hruban RH, Adsay NV, Tuveson DA and
Hingorani SR: Kras(G12D) and Smad4/Dpc4 haploinsufficiency
cooperate to induce mucinous cystic neoplasms and invasive
adenocarcinoma of the pancreas. Cancer Cell. 11:229–243. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nikiforova MN, Khalid A, Fasanella KE,
McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH,
Krasinskas AM, et al: Integration of KRAS testing in the diagnosis
of pancreatic cystic lesions: A clinical experience of 618
pancreatic cysts. Mod Pathol. 26:1478–1487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kwon MJ, Jeon JY, Park HR, Nam ES, Cho SJ,
Shin HS, Kwon JH, Kim JS, Han B, Kim DH and Choi YL: Low frequency
of KRAS mutation in pancreatic ductal adenocarcinomas in Korean
patients and its prognostic value. Pancreas. 44:484–492.
2015.PubMed/NCBI
|
|
47
|
Kanda M, Matthaei H, Wu J, Hong SM, Yu J,
Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B and Goggins
M: Presence of somatic mutations in most early-stage pancreatic
intraepithelial neoplasia. Gastroenterology. 142(730–733):
e92012.
|
|
48
|
Löhr M, Klöppel G, Maisonneuve P,
Lowenfels AB and Lüttges J: Frequency of K-ras mutations in
pancreatic intraductal neoplasia associated with pancreatic ductal
adenocarcinoma and chronic pancreatitis: A meta-analysis.
Neoplasia. 7:17–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shi C, Hong SM, Lim P, Kamiyama H, Khan M,
Anders RA, Goggins M, Hruban RH and Eshleman JR: KRAS2 mutations in
human pancreatic acinar-ductal metaplastic lesions are limited to
those with PanIN: Implications for the human pancreatic cancer cell
of origin. Mol Cancer Res. 7:230–236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
di Magliano MP and Logsdon CD: Roles for
KRAS in pancreatic tumor development and progression.
Gastroenterology. 144:1220–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jang JY, Park YC, Song YS, Lee SE, Hwang
DW, Lim CS, Lee HE, Kim WH and Kim SW: Increased K-ras mutation and
expression of S100A4 and MUC2 protein in the malignant intraductal
papillary mucinous tumor of the pancreas. J Hepatobiliary Pancreat
Surg. 16:668–674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chung SM, Hruban RH, Iacobuzio-Donahue CA,
Adsay NV, Zee SY and Klimstra DS: Analysis of molecular alterations
and differentiation pathways in intraductal oncocytic papillary
neoplasm of the pancreas. Mod Pathol. 18:277A–288A. 2005.
|
|
53
|
Kim J, Jang KT, Park Mo S, Lim SW, Kim JH,
Lee KH, Lee JK, Heo JS, Choi SH, Choi DW, et al: Prognostic
relevance of pathologic subtypes and minimal invasion in
intraductal papillary mucinous neoplasms of the pancreas. Tumour
Biol. 32:535–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
